Skip to main content
Home
Health~Holland

Main navigation

  • News
  • Events
    • International Events
    • Financial Support Network Activities
  • Public-Private Partnerships
    • Programs
    • Projects
    • Strategic Partnerships
  • Funding Opportunities
    • Science for Industry Call 2026
    • Organ-on-Chip Call
    • Eureka biotech call
    • PPS-Oproep 2026 Kennis- en Innovatieagenda Landbouw, Water Voedsel
  • Startups and SMEs
    • Innovation Brokers
    • Startups and SMEs
  • International
    • Internationalization
    • The Dutch Life Sciences & Health ecosystem
    • Country-specific information
    • Dutch LSH Network
    • Tools to get started
  • About Us
    • About us
    • Our Team
    • Vacancies
    • Publications
  • en
  • nl

Cyclomics: Winner of the Venture Challenge Fall 2017

Cyclomics: Winner of the Venture Challenge Fall 2017

EMA to relocate to Amsterdam, the Netherlands

EMA to relocate to Amsterdam, the Netherlands

Building on Cures Act, FDA lays out cell therapy fast track in regenerative medicine framework

Building on Cures Act, FDA lays out cell therapy fast track in regenerative medicine framework

AJCC Confirms MammaPrint’s Clinical Utility for Treatment Decisions and Staging in Recent 8th Edition Breast Chapter Update

AJCC Confirms MammaPrint’s Clinical Utility for Treatment Decisions and Staging in Recent 8th Edition Breast Chapter Update

Animal-friendly and effective medicine test Mimetas receives second innovation credit

Animal-friendly and effective medicine test Mimetas receives second innovation credit

Xeltis Closes €45 Million Series C Financing

Xeltis Closes €45 Million Series C Financing

hDMT seeks collaborators for €4M NWO-TTW Perspectief Program proposal

hDMT seeks collaborators for €4M NWO-TTW Perspectief Program proposal

Unique collaboration IPH with the four big healthcare insurers

Unique collaboration IPH with the four big healthcare insurers

Your chance to determine which countries & regions get priority!

Your chance to determine which countries & regions get priority!

Starting capital for Amylon Therapeutics

Starting capital for Amylon Therapeutics

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • Current page 60
  • Page 61
  • Page 62
  • Page 63
  • Page 64
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Don't miss our updates

Leave your email address to receive the latest news.

Subscribe

Stay connected

Follow us on Social Media:

Instagram LinkedIn YouTube

Contact

Health~Holland

info@health-holland.com
www.health-holland.com
+31 (0)70 205 1400 

Visiting address:
Wilhelmina van Pruisenweg 104
2595 AN The Hague

Logo NL

© 2026, Health-Holland Privacy  Complaint Regulation
HealthHolland Logo